🔎 Trials Near Me

Utama › Kanser Pundi Kencing Bukan Invasif Otot › New York › New York City

Kajian klinikal Kanser Pundi Kencing Bukan Invasif Otot di New York City, NY

10 kajian untuk Kanser Pundi Kencing Bukan Invasif Otot sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Mengambil pesertaFasa 2
  • Icahn School of Medicine at Mount Sinai, New York
  • Weill Cornell Medical Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06503614

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Mengambil pesertaFasa 3
  • Veterans Affairs New York Harbor Healthcare System-Manhattan Campus, New York
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Mengambil pesertaFasa 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Mengambil pesertaFasa 2
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06995677

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Mengambil pesertaFasa 1
  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
  • Memorial Sloan Kettering Cancer Center 53rd street, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • dan 3 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07206225

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Mengambil pesertaFasa 2
  • Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Mengambil pesertaFasa 1
  • New York University (NYU), New York
  • Weill Cornell Medicine, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Mengambil pesertaFasa 3
  • Columbia University (Data Collection Only), New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umur 21 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06929286

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT05126472

Blue Light Cystoscopy With Cysview® Registry

Mengambil pesertaKajian pemerhatian
  • NYU Langone's Perlmutter Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Dis 2025 · NCT02660645

Kajian Kanser Pundi Kencing Bukan Invasif Otot di bandar lain

Kajian lain di New York City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.